The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients

Scandinavian Journal of Urology and Nephrology

Volumn 37, Issue 1, 2003, Pages 71-76

  Cavdar, Caner ^a   Sayan, Murat ^a   Sifil, Aykut ^a   Artuk, Cigdem ^b   Yilmaz, Nezihe ^b   Bahar, Hakki ^a   Camsari, Taner ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Refik Saydam Hifzissihha Merkezi   (Turkey)

Author keywords

CAPD; Hemodialysis; Influenza; Influenza vaccination; Tx

Indexed keywords

ANTIGEN; HEMAGGLUTININ; INFLUENZA VACCINE; PROTECTIVE AGENT; VIRUS VACCINE;

ADULT; AMBULATORY CARE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMMERCIAL PHENOMENA; COMPARATIVE STUDY; CONTROLLED STUDY; DELTOID MUSCLE; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HEMODIALYSIS; HUMAN; IMMUNITY; INFLUENZA VACCINATION; KIDNEY TRANSPLANTATION; MALE; MEASUREMENT; PATIENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; RANK SUM TEST; SEROCONVERSION; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; VACCINATION; VIRUS; VIRUS STRAIN; WILCOXON SIGNED RANKS TEST;

ADULT; AGED; ANTIBODY FORMATION; FEMALE; HUMANS; IMMUNITY, ACTIVE; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS;

EID: 0345505343     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590310008749     Document Type: Article

References (36)

1. Douglas RG. Drug therapy: prophylaxis and treatment of influenza. N Engl J Med 1990; 322(7): 443-50.
2. Grist RN, Reid D. Influenza immunization. Immunization in practice. 1987; 15: 1068-74.
3. Grotto I, Mandel Y, Green MS, et al. Influenza vaccine efficacy in young, healthy adults. Clin Infect Dis 1998; 26: 913-7.
4. Hall CB. Influenza. Pediatrics 1987; 79: 564-6.
5. Wilson R. Influenza vaccination. Thorax 1994; 49: 1079-80.
6. Chaloupka I, Schuler A, Marschall M, Meier-Ewert H. Comparative analysis of six european influenza vaccines. Eur J Clin Microbiol Infect Dis 1996; 15: 121-7.
7. U.S. Department of Health and Human Services, Public Health Service - Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). Morb Mortal Wkly Rep (MMWR) 1997; 46 (RR-9): 1-16.
8. Gardner P, Schaffner W. Immunization of adults. N Engl J Med 1993; 328(17): 1252-8.
9. Mostow SR, Cate TR, Ruben FL. Prevention of influenza and pneumonia. Am Rev Respir Dis 1990; 142: 487-8.
10. Nichol KL, Margolis KL, Wuorenma RNJ, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331(12): 778-84.
11. Glathe H, Lange W. Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents. Drugs Aging 1995; 6(5): 368-87.
12. Tamura SI, Kurata H, Funato H, Nagamine T, Aizawa C, Kurata T. Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit. Vaccine 1989; 7: 314-20.
13. Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993; 270(16): 1956-61.
14. Descamps B, Chatenoud L. Effects on the immune response. In: Cameron S, Davison AM, Grünfeld JP, Kerr DN, Ritz E, Winearls CG, eds. Oxford Textbook of Clinical Nephrology. 2nd ed. New York: Oxford University Press 1998; 1982-9.
15. Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992; 22(6): 434-46.
16. Kreft B, Klouche M, Kreft R, Kirchner H, Sack K. Low efficiency of active immunization against diphtheria in chronic hemodialysis patients. Kidney Int 1997; 52: 212-6.
17. Remuzzi G, Rossi EC. Hematologic consequences of renal failure. In: Brenner BM, ed. The Kidney. 5th ed. USA: W. B. Saunders Company: 1996: 2170-86.
18. Bargman JM, Oreopulos DG. Complications other than peritonitis or those related to the catheter and the fate of uremic organ dysfunction in patients receiving peritoneal dialysis. In: Nolph KD, ed. Peritoneal Dialysis. 3rd ed. Netherlands: Kluwer Academic Publishers: 1990: 289-310.
19. Danovitch GM. Immunosuppressive medications and protocols for kidney transplantation. In: Danovitch GM, ed. Handbook of Kidney Transplantation. 3rd ed. USA: Lippincott Williams and Wilkins: 2001: 62-111.
20. Peter WL, Clark JL, Levos OM. Drug therapy in haemodialysis patients. Special considerations in the elderly. Drugs Aging 1998; 12(6): 441-59.
21. Rautenberg P, Teifke I, Schlegelberger T, Ullmann U. Influenza subtype-specific IgA, IgM, and IgG responses in patients on hemodialysis after influenza vaccination. Infection 1988; 16: 322-8.
22. Zei T, Neri M, Iorio AM. Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age. Vaccine 1991; 9: 613-6.
23. Nicholson KG, Snacken R, Palache AM. Influenza immunization policies in Europe and the United States. Vaccine 1995; 13(4): 365-9.
24. Berry BB, Murthy VS. Exceeding the healthy people 2000 goal for influenza vaccination through a collaborative effort at eight primary care clinics. Wis Med J 95(10): 705-10.
25. Heilman C, Montagne JR. Influenza: Status and prospects for its prevention, therapy, and control. Pediat Clin North Am 1990; 37(3): 669-81.
26. Suki WN, Eknoyan G. Pathophysiology and clinical manifestations of chronic renal failure and the uremic syndrome. In: Jacobson HR, Striker GE, Klahr S, eds. The Principles and Practice of Nephrology. 2nd ed. USA: Mosby 1995: 603-20.
27. Dogliani M, Fidelio T, Scalzo B, et al. Effectiveness of influenza vaccination in patients undergoing regular dialysis treatments. Minerva Urol Nefrol 1997; 49(3): 121-4.
28. Fuchshuber A, Kühnemund O, Keuth B, Lütticken R, Michalk D, Querfeld U. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 1996; 11: 468-73.
29. Fedson DS. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996. Clin Infect Dis 1998; 26: 1117-23.
30. Tolkoff-Rubin NE, Rubin RH. Infection in renal transplant patient. In: Jacobson HR, Striker GE, Klahr S, eds. The Principles and Practice of Nephrology. 2nd ed. USA: Mosby 1995; 826-33.
31. Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22: 295-302.
32. Briggs WA, Rozek RJ, Migdal SD, et al. Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann Intern Med 1980; 92: 471-7.
33. Nikoskelainen J, Vaananen P, Forsstrom J, Kasanen A. Influenza vaccination in patients with chronic renal failure. Scand J Infect Dis 1982; 14(4): 245-51.
34. Osonloo EO, Berlin BS, Popli S, et al. Antibody responses to influenza vaccination in patients with chronic renal failure. Kidney Int 1978; 14(6): 614-618.
35. Mitwalli A. Responsiveness to hepatitis B vaccine in immunocompromised patients by doubling the dose scheduling. Nephron 1996; 73(3): 417-20.
36. Keren G, Segev S, Morag A, Zakay-Rones Z, Barzilai A, Rubinstein E. Failure of influenza vaccination in the aged. J Med Virol 1988; 25: 85-9.